Switzerland on Monday approved Moderna's Covid-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.
The Swissmedic regulatory authority, which has already approved the Pfizer-BioNTech jab for over-12s, said results from an ongoing study showed Moderna had 93 percent efficacy in the young age group.
"The vaccine produced a similar immune response... in this study compared to young adults aged 18 to 25 years," the regulator said.
Switzerland, which is not in the European Union, has its own regulatory process and was the first country in continental Europe to start using the Pfizer-BioNTech jab.
The country has doled out more than 9.1 million doses and nearly 49.2 percent of the population of 8.6 million are now fully vaccinated.
However, take-up has slowed in recent weeks. Nearly 2.5 million doses were administered in June but fewer than 1.4 million in July.
The virus has killed 10,354 people in Switzerland and 723,907 positive tests have been registered.
Moderna's Covid-19 jab is used in 48 countries, behind AstraZeneca (161), Pfizer-BioNTech (88) and Sinopharm (49), according to an AFP count.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
"Press Button To Die": Switzerland To Soon Use Portable Suicide Pods "Press This Button": Portable Suicide Pod To Be Used In Switzerland Soon Xherdan Shaqiri Calls Time On Switzerland Career After 125 Caps World's Largest Isolated Tribe Makes Rare Appearance In New Footage Puja Khedkar's Mother Was Hiding In Lodge As "Indubai" Using Fake ID Why BJP Lost Lok Sabha Polls In Uttar Pradesh - 6 Reasons In Party Report Infosys Posts 7% Increase In Q1 Net Profit At Rs 6,386 Crore Watch: Rescue Teams Crawl Through Derailed Coaches Looking For Survivors Delhi Court Refers BRS leader K Kavitha To AIIMS For Medical Check-Up Track Latest News Live on NDTV.com and get news updates from India and around the world.